T. Rowe Price Associates’s ZELTIQ Aesthetics, Inc. ZLTQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-137,777
Closed -$6M 2614
2016
Q4
$6M Buy
+137,777
New +$5.55M ﹤0.01% 1397
2016
Q3
Sell
-223,359
Closed -$6.1M 2592
2016
Q2
$6.1M Hold
223,359
﹤0.01% 1369
2016
Q1
$6.07M Sell
223,359
-23,472
-10% -$553K ﹤0.01% 1364
2015
Q4
$7.04M Buy
+246,831
New +$7.79M ﹤0.01% 1361
2014
Q4
Sell
-142,923
Closed -$3.23M 2584
2014
Q3
$3.23M Sell
142,923
-397,265
-74% -$7.87M ﹤0.01% 1514
2014
Q2
$8.21M Sell
540,188
-25,005
-4% -$427K ﹤0.01% 1357
2014
Q1
$11.1M Buy
+565,193
New +$11M ﹤0.01% 1274
2013
Q4
Sell
-1,582,527
Closed -$14.4M 2536
2013
Q3
$14.4M Buy
+1,582,527
New +$11.7M ﹤0.01% 1174

Other funds holding ZLTQ

T. Rowe Price Associates's ZLTQ Position: Q1 2017 in Review

T. Rowe Price Associates sold out of ZELTIQ Aesthetics, Inc. (ZLTQ) in Q1 2017, closing a stake of 137,777 shares — an estimated $6M sold.

T. Rowe Price Associates first reported a position in ZLTQ in Q3 2013 and held it in 8 quarters. The position peaked at $14.4M in Q3 2013. 194 funds tracked by Wall St. Rank hold ZLTQ as of Q1 2017.

  • T. Rowe Price Associates reported no remaining ZELTIQ Aesthetics, Inc. position as of Q1 2017 after selling out during the quarter.
  • T. Rowe Price Associates sold 137,777 ZELTIQ Aesthetics, Inc. shares in Q1 2017, an estimated $6M.
  • T. Rowe Price Associates first reported a position in ZELTIQ Aesthetics, Inc. in Q3 2013 and held it in 8 quarters.
  • T. Rowe Price Associates's ZELTIQ Aesthetics, Inc. position peaked at $14.4M in Q3 2013.
  • 194 funds tracked by Wall St. Rank held ZELTIQ Aesthetics, Inc. as of Q1 2017.

Based on T. Rowe Price Associates's 13F filing for Q1 2017, filed 15 May 2017.